Navigation Links
Vapotherm Announces Commercial Launch of Flowrest® Homecare Device
Date:7/26/2011

STEVENSVILLE, Md., July 26, 2011 /PRNewswire-USNewswire/ -- Vapotherm announced today the launch of Flowrest®, a High Flow Therapy device developed specifically for homecare and other low acuity environments. The initial launch will focus on the U.S. and European markets.

Vapotherm's Flowrest® is designed specifically for chronic respiratory patients in home and other extended care environments.  According to the World Health Organization, chronic respiratory diseases impact hundreds of millions of people worldwide, with asthma and COPD alone totaling almost 300 million globally.  Other chronic conditions include allergic rhinitis, pulmonary fibrosis and pulmonary hypertension.  In the U.S. alone, COPD affects more than 16 million and over 1 million patients are prescribed long-term oxygen therapy.  Flowrest® is indicated to deliver heated, humidified breathing gases via nasal cannula at flow rates from 15 to 35 liters per minute.

"In response to pre-launch demand, we are excited to begin shipping Flowrest® to our customers in the U.S. and Europe," said Nick Macmillan, Home Care Segment Manager at Vapotherm.  "The Flowrest® provides patients with a new option for respiratory assistance that overcomes the well documented issues associated with mask therapies including problems with patient compliance and comfort.  Through our patented technology, we have empowered the simple and comfortable nasal cannula to provide higher levels of respiratory support."

Robert Storey, CEO of Vapotherm, commenting on the launch stated, "We wanted to provide a solution to the constant requests we received from hospital customers for a homecare option.  Worldwide, health care systems are looking for ways to get patients out of the hospital faster and sustain them at home to minimize the risk that they will have to return to the hospital.  Flowrest® is our answer to the continuity of care in High Flow Therapy."

Vapotherm has been the leading provider of High Flow Therapy devices to hospitals for over ten years, and created the category of High Flow Nasal Cannula beginning in 2001 with its first device, the 2000i.  The Company's flagship product, the Precision Flow®, is currently used in hospitals worldwide in adult, pediatric and neonatal applications.  The Flowrest® was created to fill the need for High Flow Therapy outside of the short term acute care environment.

Vapotherm, Inc. is a privately held manufacturer of respiratory care devices for hospitals and homecare use based in Stevensville, Maryland. The Company is dedicated to the development of innovative, noninvasive respiratory therapy technologies, especially for the treatment of acute and chronic breathing disorders. For more information, visit www.vtherm.com.

Vapotherm, Inc.
198 Log Canoe Circle
Stevensville, MD 21666
Phone (410) 604-3977
Fax (410) 604-3978

Contact:  Kevin Thibodeau, Executive Vice President of Sales and Marketing
410-604-3977


'/>"/>
SOURCE Vapotherm, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vapotherm Announces Approval in Canada for New High Flow Device Designed for Heliox
2. Vapotherm Announces New Exclusive Distribution Agreement with Hippo Medical for South Korea
3. Vapotherm® Receives FDA 510(k) Clearance for Flowrest® Homecare Device
4. Vapotherm, Inc. Announces CE Mark Approval for Flowrest® Homecare Device
5. Accuray Announces Proposed Offering of $75 Million Convertible Senior Notes
6. arGEN-X Announces Non-Exclusive License With BioWa for POTELLIGENT® Technology
7. NuMe Health Announces Closing of Series A-1 Financing Round
8. Amgen Announces Webcast of 2011 Second Quarter Financial Results
9. Lanx, Inc. Announces Aspen™ Spinous Process Fixation System Clinical Data at IMAST
10. Prasco® Announces Authorized Generic Agreement with Shionogi Inc.
11. Cornerstone Pharmaceuticals Announces The Journal of Molecular Medicines Publication of Research Showing Selective Inhibition of Cancer Cell Energy Metabolism With Its Novel Lipoate Derivative Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016 PRO-DEX, INC. (NasdaqCM: PDEX) today ... December 31, 2015. The Company also filed its Quarterly Report ... 2016 with the Securities and Exchange Commission today. ... 2015 --> --> Net ... $2.6 million, or 95%, to $5.4 million from $2.8 million ...
(Date:2/11/2016)... , Feb. 11, 2016 Laboratory ... used in laboratories. These may range from microscope slides ... glassware is made from borosilicate glass because of its ... on the other hand, started gaining popularity over the ... easier to replace glass with plastic in several applications ...
(Date:2/11/2016)... SAN FRANCISCO , Feb. 11, 2016  Kindred ... focused on saving and improving the lives of pets, ... Technical Section of the New Animal Drug Application (NADA) ... the pivotal field study (KB0120) of Zimeta for the ... by the Company. --> ...
Breaking Medicine Technology:
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... (DMPG) will use the action analytics leader’s population health solutions, MDinsight® and ... clinical support to the Atlanta-area healthcare system. Details of the contract were not ...
(Date:2/11/2016)... ... February 11, 2016 , ... Student-doctors from Western ... (AOA) Match Program Tuesday, February 9, taking one of the final steps in ... medical education positions across the country. Of the 103 student-doctors who comprise the ...
(Date:2/11/2016)... ... February 11, 2016 , ... Registered nurses, licensed practical nurses ... titled, “Stroke Management: Time to Act, Time to Heal” on Thursday, February 25 from ... N.J. The presenter is Vishal Chedda, president of ANSA Consultants, who will discuss clinical ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... performing a wide range of cosmetic procedures. Along with performing procedures, the magazine ... and results of many cosmetic procedures. One of the most common procedures he ...
(Date:2/11/2016)... ... February 11, 2016 , ... Florida Hospital presents Heart Health Awareness ... St. Louis Blues at the Amalie Arena. The puck drops at 6:00pm, but fans ... the MEGA Heart, prior to the game. The MEGA Heart will be located on ...
Breaking Medicine News(10 mins):